Literature DB >> 8417790

Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.

S D Lytton1, B Mester, I Dayan, H Glickstein, J Libman, A Shanzer, Z I Cabantchik.   

Abstract

We have designed two subfamilies of lipophilic iron (III) chelators previously termed reversed siderophores (RSFs). The agents display physicochemical properties that favor extraction of iron beyond membrane barriers of Plasmodium falciparum-infected red blood cells. We studied the in vitro antimalarial potency of RSFs and their relationship to the membrane permeation properties of these agents. The mode of RSF action involves: (1) fast access to intracellular compartments of parasitized cells; (2) selective and high-affinity chelation of iron (III) from parasitized cells; (3) fast exit from cells after iron (III) complexation; and (4) exertion of cell damage on parasites exposed for 3 to 5 hours to drugs, irrespective of the stage of parasite development. These results suggest that on reaching a critical intraerythrocyte target, RSFs induce an iron deficit that parasites in general, and rings in particular, have limited capacity to restore.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417790

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  In vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum.

Authors:  Bruno Pradines; Florence Ramiandrasoa; Jean Marc Rolain; Christophe Rogier; Joel Mosnier; William Daries; Thierry Fusai; Gerhard Kunesch; Jacques Le Bras; Daniel Parzy
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells.

Authors:  F Petrat; H de Groot; U Rauen
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

3.  In vitro activities of novel catecholate siderophores against Plasmodium falciparum.

Authors:  B Pradines; F Ramiandrasoa; L K Basco; L Bricard; G Kunesch; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

4.  Chemical Determinants of antimalarial activity of reversed siderophores.

Authors:  A Tsafack; J Libman; A Shanzer; Z I Cabantchik
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

5.  Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.

Authors:  J Golenser; A Tsafack; Y Amichai; J Libman; A Shanzer; Z I Cabantchik
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Iron chelators as therapeutic agents against Pneumocystis carinii.

Authors:  G A Weinberg
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

7.  Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine.

Authors:  S L Newman; L Gootee; V Stroobant; H van der Goot; J R Boelaert
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

8.  Inhibitory effect of novel iron chelator, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) and green tea extract on growth of Plasmodium falciparum.

Authors:  Phitsinee Thipubon; Chairat Uthaipibull; Sumalee Kamchonwongpaisan; Wachiraporn Tipsuwan; Somdet Srichairatanakool
Journal:  Malar J       Date:  2015-09-30       Impact factor: 2.979

9.  Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins.

Authors:  Stanley C Xie; Con Dogovski; Eric Hanssen; Francis Chiu; Tuo Yang; Maria P Crespo; Che Stafford; Steven Batinovic; Silvia Teguh; Susan Charman; Nectarios Klonis; Leann Tilley
Journal:  J Cell Sci       Date:  2015-12-16       Impact factor: 5.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.